Remicade News and Research

RSS
Alvogen launches Inflectra into Central and Eastern Europe

Alvogen launches Inflectra into Central and Eastern Europe

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Study describes lack of positive effects in drugs, long-term data and robust direct comparisons in RA

Study describes lack of positive effects in drugs, long-term data and robust direct comparisons in RA

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Hospira receives positive opinion from EMA's CHMP for EC approval of Inflectra

Hospira receives positive opinion from EMA's CHMP for EC approval of Inflectra

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Study: Women with RA exposed to anti-tumor necrosis drugs may have increased abortion rates

Study: Women with RA exposed to anti-tumor necrosis drugs may have increased abortion rates

First Korean/U.S. workshop on drug regulation and marketing

First Korean/U.S. workshop on drug regulation and marketing

XBiotech to enter biosimilar business

XBiotech to enter biosimilar business

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

EPIRUS’ BOW-015 achieves bioequivalence to Remicade in a single dose comparator trial

EPIRUS’ BOW-015 achieves bioequivalence to Remicade in a single dose comparator trial

Ustekinumab shows positive results in decreasing debilitating effects of Crohn's Disease

Ustekinumab shows positive results in decreasing debilitating effects of Crohn's Disease

Janssen introduces new online scientific resource for U.S. healthcare professionals

Janssen introduces new online scientific resource for U.S. healthcare professionals

Study compares mortality rates among RA patients treated with individual TNF inhibitors

Study compares mortality rates among RA patients treated with individual TNF inhibitors

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Panel of HuCAL Anti-Drug Antibodies to be launched by AbD Serotec

Panel of HuCAL Anti-Drug Antibodies to be launched by AbD Serotec

New research reveals effective treatments for gastrointestinal conditions

New research reveals effective treatments for gastrointestinal conditions

Mount Sinai receives Le Foundation gift for psychiatric neuroimaging study

Mount Sinai receives Le Foundation gift for psychiatric neuroimaging study